Connection

Vincent Poon to Immunodominant Epitopes

Back to Details
This is a "connection" page, showing publications Vincent Poon has written about Immunodominant Epitopes.
Vincent Poon
Connection Strength
0.161
Immunodominant Epitopes
  1. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerg Microbes Infect. 2021 Dec; 10(1):874-884.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.